Hypoxia-inducible factor-1 (HIF-1), the central transcription factor in hypoxic tumor cells, plays a vital role in tumor cell resistance to various cancer therapies including radiation therapy, photodynamic therapy, and chemotherapy 9. Here, HIF1A is linked to cancer.